Iron chelation with deferasirox in two patients with hfe hemochromatosis and chronic anemia

Acta Haematologica

Volumn 126, Issue 2, 2011, Pages 119-121

  Nagler, M ^a   Gregor, M ^a   Wuillemin, W A ^a,b  

^a Central Hematology Laboratory   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Deferasirox; HFE hemochromatosis; Iron chelation

Indexed keywords

AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; DEFERASIROX; FERRITIN; LIVER ENZYME; MEMBRANE PROTEIN; PROTEIN HEMOCHROMATOSIS; TRANSFERRIN; UNCLASSIFIED DRUG;

AGED; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTHROPATHY; ARTICLE; BODY MASS; CASE REPORT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HEMOGLOBIN BLOOD LEVEL; HIP OSTEOARTHRITIS; HUMAN; HYPERFERRITINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; IRON CHELATION; IRON OVERLOAD; LIVER BIOPSY; LIVER DISEASE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; BENZOIC ACIDS; CHELATION THERAPY; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON CHELATING AGENTS; MALE; MEMBRANE PROTEINS; TREATMENT OUTCOME; TRIAZOLES;

EID: 79958072283     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000328039     Document Type: Article

References (7)

1. Pietrangelo A: Hereditary hemochromatosis: Pathogenesis, diagnosis, and treatment. Gastroenterology 2010; 139: 393-408, 408e 391-392.
2. Adams PC, Barton JC: How I treat hemochromatosis. Blood 2010; 116: 317-325.
3. Meerpohl JJ, Antes G, Rucker G, Fleeman N, Niemeyer C, Bassler D: Deferasirox for managing transfusional iron overload in people with sickle cell disease. Cochrane Database Syst Rev 2010:CD007477.
4. Wood JC, Kang BP, Thompson A, Giardina P, Harmatz P, Glynos T, Paley C, Coates TD: The effect of deferasirox on cardiac iron in thalassemia major: Impact of total body iron stores. Blood 2010; 116: 537-543.
5. Portmann BC, Thompson RJ, Roberts EA, Paterson AC: Genetic and metabolic liver disease; in Burt AD, Portmann BC, Ferrell LD (eds): MacSweens's Pathology of the Liver. London, Elsevier, 2005, vol 5, pp 199-326.
6. Wick M, Pinggera G, Lehmann P: Clinical Aspects and Laboratory. Iron Metabolism, Anemias: Novel Concepts in the Anemias of Malignancies and Renal and Rheumatoid Diseases. Wien, Springer, 2009.
7. Phatak P, Brissot P, Wurster M, Adams PC, Bonkovsky HL, Gross J, Malfertheiner P, McLaren GD, Niederau C, Piperno A, Powell LW, Russo MW, Stoelzel U, Stremmel W, Griffel L, Lynch N, Zhang Y, Pietrangelo A: A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology 2010; 52: 1671-1779.